Portal › Forums › Lung/Thoracic Cancer › General Lung/Thoracic Cancer › ASCO 2013 Video: How do we approach acquired resistance to targeted therapies?
This topic contains 0 replies, has 1 voice, and was last updated by JimC Forum Moderator 4 years, 6 months ago.
ASCO 2013 videos continue, as Drs. Jack West, Mary Pinder, and Nate Pennell discuss options for managing acquired resistance to EGFR TKIs and ALK inhibitors in patients with advanced NSCLC and a driver mutation.
You can view the video here: http://cancergrace.org/lung/2013/07/08/acquired-resistance-targeted-rx-asco-2013/
We welcome your questions and comments here.
Jul 2008 Wife Liz (51/never smoker) Dx Stage IV NSCLC EGFR exon 19
4 cycles Carbo/alimta, 65% shrinkage
Mar 2010 progression, added Alimta, stable
Sep 2010 multiple brain mets, WBR
Oct 2010 large pericardial effusion, tamponade
Jan 2011 progression, start abraxane
Jun 2011-New liver, brain mets, add Tarceva
Oct 2011-Dx Leptomeningeal carcinomatosis; pulsed Tarceva
At rest Nov 4 2011
Since then: http://cancergrace.org/blog/jim-and-lisa
You must be logged in to reply to this topic.
Subscribe toGRACE Notes (Free Newsletter)
Mission | Disclaimer